LRMR

Q: What is the price of Larimar Therapeutics (LRMR) today?

The current price of Larimar Therapeutics (LRMR) is $ 3.59, representing a 24.65% gain over the past year. The stock began the year trading around $ 3.81 and is currently priced at $ 3.59. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Larimar Therapeutics (LRMR) pay dividends?

Larimar Therapeutics (LRMR) did not pay dividends over the past year.

Larimar Therapeutics Inc.

Price

$ 3.59

return (12m)

24.65%

p/e

-1.88

p/bv

1.97

DIVIDEND YIELD

0.00%

LRMR price

Larimar Therapeutics

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LRMR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.28%

3 months

-18.04%

1 year

24.65%

2 years

-61.77%

5 years

-57.31%

10 years

-95.08%

Fundamentals LRMR

review the fundamentals of Larimar Therapeutics shares

P/E

-1.88

Sector: -3.80 Industry: -3.80

P/S (PSR)

Sector: -4.18 Industry: -4.18

P/BV

1.97

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-79.61%

Sector: -65.32% Industry: -65.32%

ROE

-105.04%

Sector: -66.07% Industry: -66.07%

ROIC

-2,615.70%

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

0.00%

Sector: -40.34% Industry: -40.34%

GROSS MARGIN

0.00%

Sector: 36.85% Industry: 36.85%

OPERATING MARGIN

0.00%

Sector: -39.20% Industry: -39.20%

EV/EBITDA

-1.81

Sector: -3.89 Industry: -3.89

EV/EBIT

-1.81

Sector: -3.98 Industry: -3.98

PRICE-TO-ASSETS

1.50

Sector: 1.42 Industry: 1.42

BVPS

1.76

Sector: 1.86 Industry: 1.86

EPS

-1.84

Sector: -2.12 Industry: -2.12

EQUITY-TO-ASSETS RATIO

0.76

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.24

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

26.81%

Sector: - Industry: -

Fundamentals LRMR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	65.46	40.20	61.41%	4.25%	$ 195.21 B	37.07%
MRK	32.94	6.41	19.45%	2.79%	$ 294.29 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	16.93	6.66	39.33%	2.54%	$ 155.98 B	30.99%
BMY	16.00	5.79	36.19%	4.38%	$ 116.43 B	15.01%
ZTS	12.70	10.39	81.75%	2.59%	$ 33.58 B	27.79%
REGN	14.39	2.03	14.08%	0.59%	$ 63.66 B	29.65%
HALO	23.51	37.34	158.82%	0.00%	$ 8.20 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	20.09	-114.69	-570.98%	0.40%	$ 95.65 B	1.18%
HRMY	13.72	2.20	16.00%	0.00%	$ 2.00 B	16.20%
VRTX	26.05	5.84	22.41%	0.00%	$ 113.01 B	35.51%
CAH	33.83	-19.69	-58.20%	0.91%	$ 52.60 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LRMR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Larimar Therapeutics

Larimar Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

2020

Time since IPO - 6 years

28

Employees

Larimar Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $311.85 Millions, with shareholders equity totaling $158.03 Millions.

The company employs approximately 28 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Larimar Therapeutics Inc. reported $- in revenue, generating net income of $-166.00 Millions.

Key financial metrics include a P/E ratio of -1.88, a price-to-book (P/B) ratio of 1.97, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LRMR.

Market cap

$ 311.85 Millions

Net worth

$ 158.03 Millions

$ 158,030,000.00

Assets

$ 208.51 Millions

$ 208,510,000.00

Total Shares Outstanding

90.00 Millions

90,000,000

Average Daily Trading Volume

$ 1.68 Million

$ 1,680,032.00

Sector

Health Care

Industry

Biotechnology

LRMR

LRMR revenue and profits

Financial Results LRMR

DRAG THE FRAME TO SEE MORE DATA

LRMR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 779.78 8,92% (12M)

P/E

20.09

0.40%

ROE

-570.98%

P/BV

-114.69

CAH - Cardinal Health

$ 226.40 41,32% (12M)

P/E

33.83

0.91%

ROE

-58.20%

P/BV

-19.69

JNJ - Johnson & Johnson

$ 235.66 55,63% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

MRK - Merck & Co.

$ 114.90 48,09% (12M)

P/E

32.94

2.79%

ROE

19.45%

P/BV

6.41

AZN - AstraZeneca

$ 177.27 27,08% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 221.59 19,79% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

PFE - Pfizer

$ 26.00 14,03% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 779.78 8,92% (12 M)

P/L

20.09

0.40%

ROE

-570.98%

P/VP

-114.69

CAH - Cardinal Health

$ 226.40 41,32% (12 M)

P/L

33.83

0.91%

ROE

-58.20%

P/VP

-19.69

JNJ - Johnson & Johnson

$ 235.66 55,63% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

MRK - Merck & Co.

$ 114.90 48,09% (12 M)

P/L

32.94

2.79%

ROE

19.45%

P/VP

6.41

AZN - AstraZeneca

$ 177.27 27,08% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 221.59 19,79% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

PFE - Pfizer

$ 26.00 14,03% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

Frequently Asked Questions

What is the price of Larimar Therapeutics (LRMR) today?

The current price of Larimar Therapeutics (LRMR) is $ 3.59, representing a 24.65% gain over the past year. The stock began the year trading around $ 3.81 and is currently priced at $ 3.59. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Larimar Therapeutics (LRMR) pay dividends?

Larimar Therapeutics (LRMR) did not pay dividends over the past year.

Is Larimar Therapeutics (LRMR) a good investment?

Larimar Therapeutics (LRMR) is currently trading at $ 3.59 with a P/E ratio of -1.88. This represents a -280% premium compared to its historical average P/E. Over the past year, the stock has gained 24.65 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 24.65%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Larimar Therapeutics (LRMR) stock?

You can buy Larimar Therapeutics (LRMR) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LRMR and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Larimar Therapeutics (LRMR) yield today?

Over the past month, Larimar Therapeutics (LRMR) has returned 0.28% — 24.65% over the past year, and -57.31% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Larimar Therapeutics (LRMR) today at the current price of $ 3.59 your total investment would be $ 359.00.

Based on historical performance, the investment would have grown to approximately:

$ 447.49 after 1 year
$ 153.26 after 5 years
$ 17.66 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LRMR

Larimar Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LRMR

review the fundamentals of Larimar Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Larimar Therapeutics

Larimar Therapeutics Inc.

United States

21 years

2020

28

PROFIT X PRICE LRMR

Financial Results LRMR

LRMR cash flow

Asset, Revenue and Profit Growth - LRMR

LRMR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions